We’re excited to present our latest data on tumor-targeted antibody-drug conjugates (ADCs) at ESMO 2025 in Berlin. Join us to discover how our proprietary platform technologies are reshaping the future of targeted cancer therapies.

The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.